Leukosight Overview

  • Founded
  • 2006
  • Status
  • Private
  • Employees
  • 5
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 5

Leukosight General Information


Provider of anti-inflammatory therapeutics. The company offers therapeutics that can be used to treat auto-immune and inflammatory diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 1107 Microbiology Building
  • 231 B Campus Drive
  • College Park, MD
  • United States
+1 (301) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Leukosight Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private Completed Generating Revenue
4. Grant 30-Apr-2014 00000 Completed Startup
3. Grant 10-Jul-2012 00000 Completed Startup
2. Early Stage VC Completed Startup
1. Grant 01-May-2009 $150K Completed Startup
To view Leukosight’s complete valuation and funding history, request access »

Leukosight Executive Team (1)

Name Title Board Seat Contact Info
David Mosser Ph.D Chief Executive Officer
To view Leukosight’s complete executive team members history, request access »

Leukosight Board Members (3)

Name Representing Role Since
Gary Noel Leukosight Board Member 000 0000
Steven Burke MD Self Board Member 000 0000
To view Leukosight’s complete board members history, request access »

Leukosight Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Leukosight Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
Maryland Biotechnology Center Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
Maryland Small Business Development Center Accelerator/Incubator 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0
To view Leukosight’s complete investors history, request access »